Rejuvenation of senescent cells-The road to postponing human aging and age-related disease?

Experimental Gerontology

Volumn 48, Issue 7, 2013, Pages 661-666

  Sikora, Ewa ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

Author keywords

Age related disease; DNA damage; IPSCs; Low grade inflammation; Secretory phenotype; Senescence; Telomeres

Indexed keywords

BETA GALACTOSIDE; HISTONE H2AX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38;

AGE; AGING; ARTICLE; CARCINOGENESIS; CELL AGING; CELL COUNT; CELL CYCLE ARREST; CELL DIVISION; CELL FATE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SELECTION; CELL STRESS; CELL TRANSFORMATION; DISEASE MARKER; DNA DAMAGE; DNA MODIFICATION; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; FIBROBLAST; GENE EXPRESSION PROFILING; GENETIC MANIPULATION; GERIATRIC DISORDER; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; LIFESPAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; NUCLEAR REPROGRAMMING; NUTRITION; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REJUVENATION; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; TELOMERE; TELOMERE SHORTENING; TUMOR CELL;

AGE FACTORS; AGING; ANIMALS; CELL AGING; DNA DAMAGE; GENE EXPRESSION REGULATION; HUMANS; REJUVENATION; TELOMERE;

ANIMALIA;

EID: 84879019836     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.09.008     Document Type: Article

References (80)

1. Agarwal S., Loh Y.H., McLoughlin E.M., Huang J., Park I.H., Miller J.D., Huo H., Okuka M., Dos Reis R.M., Loewer S., Ng H.H., Keefe D.L., Goldman F.D., Klingelhutz A.J., Liu L., Daley G.Q. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 2010, 464:292-296.
2. Ali R.E., Rattan S.I. Curcumin's biphasic hormetic response on proteasome activity and heat-shock protein synthesis in human keratinocytes. Ann. N. Y. Acad. Sci. 2006, 1067:394-399.
3. Aubert G., Lansdorp P.M. Telomeres and aging. Physiol. Rev. 2008, 88:557-579.
4. Baker D.J., Wijshake T., Tchkonia T., LeBrasseur N.K., Childs B.G., van de Sluis B., Kirkland J.L., van Deursen J.M. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011, 479:232-236.
5. Blagosklonny M.V. Progeria, rapamycin and normal aging: recent breakthrough. Aging (Albany NY) 2011, 3:685-691.
6. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
7. Brack C., Lithgow G., Osiewacz H., Toussaint O. EMBO WORKSHOP REPORT: molecular and cellular gerontology Serpiano, Switzerland, September 18-22, 1999. EMBO J. 2000, 19:1929-1934.
8. Brunner S., Herndler-Brandstetter D., Arnold C.R., Wiegers G.J., Villunger A., Hackl M., Grillari J., Moreno-Villanueva M., Burkle A., Grubeck-Loebenstein B. Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death. Aging Cell 2012, 4:579-587.
9. Brzezinska A., Magalska A., Sikora E. Proliferation of CD8+ in culture of human T cells derived from peripheral blood of adult donors and cord blood of newborns. Mech. Ageing Dev. 2003, 124:379-387.
10. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: what is the connection?. Nat. Rev. Mol. Cell Biol. 2012, 11:567-578.
11. Burton D.G., Matsubara H., Ikeda K. Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells. Exp. Gerontol. 2010, 45:819-824.
12. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
13. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120:513-522.
14. Campisi J., Andersen J.K., Kapahi P., Melov S. Cellular senescence: a link between cancer and age-related degenerative disease?. Semin. Cancer Biol. 2011, 21:354-359.
15. Cao K., Graziotto J.J., Blair C.D., Mazzulli J.R., Erdos M.R., Krainc D., Collins F.S. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 2011, 3:89ra58.
16. Cichowski K., Hahn W.C. Unexpected pieces to the senescence puzzle. Cell 2008, 133:958-961.
17. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 2008, 8:512-522.
18. Davalos A.R., Coppe J.P., Campisi J., Desprez P.Y. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 2010, 29:273-283.
19. Effros R.B., Dagarag M., Valenzuela H.F. In vitro senescence of immune cells. Exp. Gerontol. 2003, 38:1243-1249.
20. Erusalimsky J.D. Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 2009, 106:326-332.
21. Finch C.E., Morgan T.E. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr Alzheimer Res. 2007, 4:185-189.
22. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
23. Freedman D.A. Senescence and its bypass in the vascular endothelium. Front. Biosci. 2005, 10:940-950.
24. Fridman A.L., Tainsky M.A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 2008, 27:5975-5987.
25. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., Bucci G., Dobreva M., Matti V., Beausejour C.M., Herbig U., Longhese M.P., d'Adda di Fagagna F. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 2012, 14:355-365.
26. Geng Y.Q., Guan J.T., Xu X.H., Fu Y.C. Senescence-associated beta-galactosidase activity expression in aging hippocampal neurons. Biochem. Biophys. Res. Commun. 2010, 396:866-869.
27. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
28. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961, 25:585-621.
29. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
30. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708.
31. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
32. Jeyapalan J.C., Sedivy J.M. Cellular senescence and organismal aging. Mech. Ageing Dev. 2008, 129:467-474.
33. Jun J.I., Lau L.F. Cellular senescence controls fibrosis in wound healing. Aging (Albany NY). 2010, 2:627-631.
34. Kirkwood T.B. A systematic look at an old problem. Nature 2008, 451:644-647.
35. Kreiling J.A., Tamamori-Adachi M., Sexton A.N., Jeyapalan J.C., Munoz-Najar U., Peterson A.L., Manivannan J., Rogers E.S., Pchelintsev N.A., Adams P.D., Sedivy J.M. Age-associated increase in heterochromatic marks in murine and primate tissues. Aging Cell 2011, 10:292-304.
36. Krizhanovsky V., Yon M., Dickins R.A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S.W. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
37. Ksiazek K. A comprehensive review on mesenchymal stem cell growth and senescence. Rejuvenation Res. 2009, 12:105-116.
38. Kuilman T., Michaloglou C., Vredeveld L.C., Douma S., van Doorn R., Desmet C.J., Aarden L.A., Mooi W.J., Peeper D.S. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
39. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. The essence of senescence. Genes Dev. 2011, 24:2463-2479.
40. Lapasset L., Milhavet O., Prieur A., Besnard E., Babled A., Ait-Hamou N., Leschik J., Pellestor F., Ramirez J.M., De Vos J., Lehmann S., Lemaitre J.M. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev. 2011, 25:2248-2253.
41. Leroi A.M., Bartke A., De Benedictis G., Franceschi C., Gartner A., Gonos E.S., Fedei M.E., Kivisild T., Lee S., Kartaf-Ozer N., Schumacher M., Sikora E., Slagboom E., Tatar M., Yashin A.I., Vijg J., Zwaan B. What evidence is there for the existence of individual genes with antagonistic pleiotropic effects?. Mech. Ageing Dev. 2005, 126:421-429.
42. Liu L., Rando T.A. Manifestations and mechanisms of stem cell aging. J. Cell Biol. 2012, 193:257-266.
43. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
44. Menendez J.A., Vellon L., Oliveras-Ferraros C., Cufi S., Vazquez-Martin A. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging. Cell Cycle 2011, 10:3658-3677.
45. Minamino T. Role of cellular senescence in lifestyle-related disease. Circ. J. 2010, 74:2527-2533.
46. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 2007, 100:15-26.
47. Mondello C., Petropoulou C., Monti D., Gonos E.S., Franceschi C., Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp. Cell Res. 1999, 248:234-242.
48. Mosieniak G., Adamowicz M., Alster O., Jaskowiak H., Szczepankiewicz A.A., Wilczynski G.M., Ciechomska I.A., Sikora E. Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy. Mech. Ageing Dev. 2012, 133:444-455.
49. Nakamura A.J., Chiang Y.J., Hathcock K.S., Horikawa I., Sedelnikova O.A., Hodes R.J., Bonner W.M. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenetics Chromatin. 2008, 1:6.
50. Nardella C., Clohessy J.G., Alimonti A., Pandolfi P.P. Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 2011, 11:503-511.
51. Ohmine S., Squillace K.A., Hartjes K.A., Deeds M.C., Armstrong A.S., Thatava T., Sakuma T., Terzic A., Kudva Y., Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging (Albany NY). 2012, 4:60-73.
52. Olivieri F., Mazzanti I., Abbatecola A.M., Recchioni R., Marcheselli F., Procopio A.D., Antonicelli R. Telomere/telomerase system: a new target of statins pleiotropic effect?. Curr. Vasc. Pharmacol. 2012, 10:216-224.
53. Prieur A., Peeper D.S. Cellular senescence in vivo: a barrier to tumorigenesis. Curr. Opin. Cell Biol. 2008, 20:150-155.
54. Puig P.E., Guilly M.N., Bouchot A., Droin N., Cathelin D., Bouyer F., Favier L., Ghiringhelli F., Kroemer G., Solary E., Martin F., Chauffert B. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol. Int. 2008, 32:1031-1043.
55. Quitschke W.W. Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation. PLoS One 2012, 7:e39568.
56. Rajaraman R., Guernsey D.L., Rajaraman M.M., Rajaraman S.R. Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int. 2006, 6:25.
57. Rando T.A., Chang H.Y. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 2012, 148:46-57.
58. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 2003, 63:2705-2715.
59. Saemann M.D., Haidinger M., Hecking M., Horl W.H., Weichhart T. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am. J. Transplant. 2009, 9:2655-2661.
60. Saliques S., Teyssier J.R., Vergely C., Lorgis L., Lorin J., Farnier M., Donzel A., Sicard P., Berchoud J., Lagrost A.C., Touzery C., Ragot S., Cottin Y., Rochette L., Zeller M. Circulating leukocyte telomere length and oxidative stress: a new target for statin therapy. Atherosclerosis 2011, 219:753-760.
61. Salvioli S., Sikora E., Cooper E.L., Franceschi C. Curcumin in cell death processes: a challenge for CAM of age-related pathologies. Evid Based Complement Alternat Med. 2007, 4:181-190.
62. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., Barrett J.C. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 2004, 6:168-170.
63. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
64. Sikora E., Bielak-Zmijewska A., Mosieniak G., Piwocka K. The promise of slow down ageing may come from curcumin. Curr. Pharm. Des. 2010, 16:884-892.
65. Sikora E., Arendt T., Bennett M., Narita M. Impact of cellular senescence signature on ageing research. Ageing Res. Rev. 2011, 10:146-152.
66. Sliwinska M.A., Mosieniak G., Wolanin K., Babik A., Piwocka K., Magalska A., Szczepanowska J., Fronk J., Sikora E. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech. Ageing Dev. 2009, 130:24-32.
67. Stampfer M.R., Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett. 2003, 194:199-208.
68. Stein G.H., Drullinger L.F., Robetorye R.S., Pereira-Smith O.M., Smith J.R. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11012-11016.
69. Strong R., Miller R.A., Astle C.M., Baur J.A., de Cabo R., Fernandez E., Guo W., Javors M., Kirkland J.L., Nelson J.F., Sinclair D.A., Teter B., Williams D., Zaveri N., Nadon N.L., Harrison D.E. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2012, Mar 26. [Electronic publication ahead of print].
70. Tacutu R., Budovsky A., Yanai H., Fraifeld V.E. Molecular links between cellular senescence, longevity and age-related diseases-a systems biology perspective. Aging (Albany NY). 2011, 3:1178-1191.
71. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
72. Takubo K., Aida J., Izumiyama-Shimomura N., Ishikawa N., Sawabe M., Kurabayashi R., Shiraishi H., Arai T., Nakamura K.-N. Changes of telomere length with aging. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S197-S206.
73. Tchkonia T., Morbeck D.E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosla S., Jensen M.D., Kirkland J.L. Fat tissue, aging, and cellular senescence. Aging Cell 2010, 9:667-684.
74. Tomaszewski M., Stepien K.M., Tomaszewska J., Czuczwar S.J. Statin-induced myopathies. Pharmacol. Rep. 2011, 63:859-866.
75. van Tuyn J., Adams P.D. Signalling the end of the line. Nat. Cell Biol. 2012, 14:339-341.
76. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128:83-91.
77. von Zglinicki T., Petrie J., Kirkwood T.B. Telomere-driven replicative senescence is a stress response. Nat. Biotechnol. 2003, 21:229-230.
78. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp. Gerontol. 2001, 36:1327-1347.
79. Wang C., Jurk D., Maddick M., Nelson G., Martin-Ruiz C., von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009, 8:311-323.
80. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.